Full-Time

Bulk Antigens Continuous Improvement

CI, Specialist-Vaccines

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Toronto, ON, Canada

Onsite presence required.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • 5+ years of experience in the pharmaceutical industry
  • 5+ years in operational roles including Quality experience
  • Experience in Lean Manufacturing and transformation programs would be an advantage
  • Experience in Project management would be an advantage
  • Experience in Team Leadership would be an advantage
Responsibilities
  • The role is to drive Industrial excellence to achieve the Process Centric Unit’s (PCU’s) Strategy and Ambition. The CI Specialist brings a high level of expertise and leadership in lean methodology, industrial performance, digital solutions, transformation and change management.
  • The main impact expected from a compliance perspective is to improve and maintain compliance of operational quality processes owned by QA to all Global Standards and regulatory commitments. Additionally, the incumbent will also support deviation investigations, change controls and CAPAs as required, and will work within the Quality System.
  • Develop and improve Data Governance at the PCU level and routinely analyse the performance of the PCU.
  • Lead CI initiatives, implement continuous improvement actions, and ensure delivery on-time and within established budgets.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?